PCI Biotech Holding ASA is a biotechnology company that specializes in the development of innovative treatments, with a particular focus on targeted cancer treatment. The company has developed a unique technology that aims to improve the effect of existing cancer drugs. Through its work, PCI Biotech contributes to progress in biotechnology and medical research.
The company works with various partners in the industry to promote research and development of new medicines. PCI Biotech has a dedicated management team with extensive experience in biotechnology, which strengthens the company's position in the market. In addition, they offer opportunities for investment and partnership, which may be of interest to players who want to get involved in the biotechnology sector.